PTH in postmenopausal osteoporotic women.

被引：0
|
作者：
Koh, LKH
Bauer, DC
Forsyth, BA
Gore, LR
Vogt, MT
Cummings, SR
机构：
[1] UNIV CALIF SAN FRANCISCO,SAN FRANCISCO,CA 94143
[2] UNIV PITTSBURGH,PITTSBURGH,PA 15260
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 1997年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：P259 / P259
页数：1
相关论文
共 50 条
  • [1] The efficacy of Alendronate in postmenopausal osteoporotic women.
    Bernad, M
    Del Campo, T
    Gonzalez, M
    Fernandez, J
    Garces, M
    Martin-Mola, E
    Martinez, M
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S526 - S526
  • [2] Comparison of "intact" and "whole" PTH assays in postmenopausal women.
    Holloway, L
    JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 : S444 - S444
  • [3] Reduction of osteoporotic fractures with risedronate in osteopenic postmenopausal women.
    Siris, ES
    Barton, IP
    McClung, MR
    Grauer, A
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S93 - S93
  • [4] Alendronate does not block the anabolic effect of PTH in postmenopausal osteoporotic women
    Cosman, F
    Nieves, J
    Woelfert, L
    Shen, V
    Lindsay, R
    JOURNAL OF BONE AND MINERAL RESEARCH, 1998, 13 (06) : 1051 - 1055
  • [5] SHOULD PTH SERUM LEVEL IN POSTMENOPAUSAL OSTEOPOROTIC WOMEN BE ROUTINELY EXAMINED?
    Wawrzyniak, A.
    Marcinkowska, M.
    Ignaszak-Szczepaniak, M.
    Nosowicz, W.
    OSTEOPOROSIS INTERNATIONAL, 2014, 25 : S311 - S311
  • [6] ESR2 influences the risk of osteoporotic fracture in postmenopausal women.
    Zillikens, MC
    Rivadeneira, F
    van Meurs, J
    Beck, T
    Houwing, J
    Hofman, A
    van Leeuwen, J
    van Duijn, C
    Pols, HA
    Uitterlinden, A
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S342 - S343
  • [7] Differential gene expression in bone tissue of postmenopausal osteoporotic and healthy women.
    Takacs, I
    Kosa, JP
    Speer, G
    Tabak, A
    Nagy, Z
    Kiss, J
    Lakatos, P
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S442 - S442
  • [8] Homocysteine serum levels predict the risk of osteoporotic fractures in postmenopausal women.
    van Meurs, JBJ
    van der Klift, M
    de Jonge, R
    Lindemans, J
    Witteman, J
    Hofman, A
    van Leeuwen, JPT
    Uitterlinden, AG
    Pols, HAP
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S146 - S146
  • [9] POSTMENOPAUSAL OSTEOPOROTIC WOMEN TREATED WITH PTH 1-84: EVALUATION OF OUTCOMES
    Pastore, Renato
    Chioma, Laura
    Borboni, Patrizia
    Vancieri, Giuseppe
    Mentuccia, Daniela
    Frajese, Giovanni Vanni
    OSTEOPOROSIS INTERNATIONAL, 2011, 22 : 395 - 395
  • [10] Cost-Effectiveness of Bazedoxifene Compared with Raloxifene in the Treatment of Postmenopausal Osteoporotic Women.
    Hiligsmann, Mickael
    Ben Sedrine, Wafa
    Reginster, J. -Y.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S834 - S834
12345